DJIA 17,265.99 109.14 0.64%
NASDAQ 4,593.43 31.24 0.68%
S&P 500 2,011.36 9.79 0.49%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

41.88 0.68 (1.65%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $41.88 1.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $42.10
Previous Close $41.20
Daily Range $41.34 - $42.22
52-Week Range $22.25 - $62.66
Market Cap $4.9B
P/E Ratio -50.86
Dividend (Yield) $0.00 (0.0%)
Volume 2,648,375
Average Daily Volume 2,095,705
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drugs

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

Jim Cramer's Top Stock Picks: ISIS DDD CY

Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Isis Pharmaceuticals (ISIS) Weak On High Volume Today

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

October 31st Options Now Available For Isis Pharmaceuticals (ISIS)

'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics

Notable ETF Inflow Detected - IWM, ISIS, GPK, ULTI

See More ISIS News...

ISIS's Top Competitors

ISIS $41.88 (1.65%)
Current stock: ISIS
AMGN $142.02 (0.93%)
Current stock: AMGN
GILD $105.93 (2.01%)
Current stock: GILD
BIIB $329.99 (0.74%)
Current stock: BIIB